Presentation

Effect of Aleglitazar on Cardiovascular Outcomes after ACS in Patients with Type 2 Diabetes

Presenter: A. Michael Lincoff

April 04, 2014

REGISTER for free or LOG IN to view this content

Effect of Aleglitazar on Cardiovascular Outcomes after ACS in Patients with Type 2 Diabetes

ACS/AMI

Coronary

Diabetes

Factoid

Up Next

Presentation Fellows 2014

High-Risk PCI and Cardiogenic Shock: The Role of Hemodynamic Support

Presenter: Ajay Kirtane

April 13, 2014

More slides +

Presentation Fellows 2014

Plaque Modification Devices and Coronary Atherectomy

Presenter: Jeffrey Moses

April 13, 2014

Presentation

Comparison of Frequency of Radial Artery Occlusion After 4-Fr vs 6-Fr Transradial Coronary Intervention

Presenter: Satoshi Takeshita

April 15, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.